Publication:
Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres

dc.contributor.authorDURMUŞOĞLU, LÜTFİYE
dc.contributor.authorsCevher, Erdal; Orhan, Zafer; Mulazimoglu, Lutfiye; Sensoy, Demet; Alper, Murat; Yildiz, Ayca; Ozsoy, Yildiz
dc.date.accessioned2022-03-12T17:21:26Z
dc.date.accessioned2026-01-11T06:21:58Z
dc.date.available2022-03-12T17:21:26Z
dc.date.issued2006
dc.description.abstractThe biodegradable chitosan microspheres containing vancomycin hydrochloride (VANCO) were prepared by spray drying method with different polymer:drug ratios ( 1: 1, 2:1, 3:1 and 4: 1). Thermal behaviour, particle size and distribution, morphological characteristics, drug content, encapsulation efficiency, in vitro release assessments of formulations have been carried out to obtain suitable formulation which shows sustained-release effect when implanted. Sterilized VANCO loaded microspheres were implanted to proximal tibia of rats with methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. Intramuscular (IM) injection of VANCO for 21 days was applied to another group for comparison. After 3 weeks of treatment, bone samples were analysed with a microbiological assay. According to the results, encapsulation efficiency and yield of microspheres in all formulations were higher than 98% and 47%, respectively. Particle sizes of microspheres were smaller than 6 mu m. All microsphere formulations have shown sustained-release effect. In vitro drug release rate decreased due to the increase in polymer:drug ratio but no significant difference was seen between these results (p > 0.05). Based on our in vivo data, rats implanted VANCO-loaded chitosan inicrospheres and administered IM injection showed 3354 3366 and 52500 25635 colony forming, unit of MRSA in 1g bone samples (CFU/g), respectively. As a result, implanted VANCO-loaded microspheres were found to be more effective than IM route for the treatment of experimental osteomyelitis. (c) 2006 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ijpharm.2006.03.014
dc.identifier.eissn1873-3476
dc.identifier.issn0378-5173
dc.identifier.pubmed16624509
dc.identifier.urihttps://hdl.handle.net/11424/228338
dc.identifier.wosWOS:000239293400004
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofINTERNATIONAL JOURNAL OF PHARMACEUTICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectvancomycin
dc.subjectbiodegradable microspheres
dc.subjectchitosan
dc.subjectspray drying method
dc.subjectmethicillin-resistant Staphylococcus aureus
dc.subjectexperimental osteomyelitis
dc.subjectIMPLANT-RELATED OSTEOMYELITIS
dc.subjectIN-VITRO
dc.subjectDELIVERY-SYSTEM
dc.subjectTREATING OSTEOMYELITIS
dc.subjectBIOABSORBABLE POLYMER
dc.subjectPECTIN MICROSPHERES
dc.subjectTOPICAL VANCOMYCIN
dc.subjectMRSA OSTEOMYELITIS
dc.subjectANTIBIOTIC RELEASE
dc.subjectPLGA MICROSPHERES
dc.titleCharacterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage135
oaire.citation.issue2
oaire.citation.startPage127
oaire.citation.titleINTERNATIONAL JOURNAL OF PHARMACEUTICS
oaire.citation.volume317

Files